Indeed, IL-4 and IL-13 signaling via the type 2 receptors orchestrate type 2 immunity to helminth infections (68) and can curtail chemotaxis and several effector functions of neutrophils in mice and humans, thereby mitigating detrimental tissue damage (66). The gene discussed is IL13; the disease is helminthiasis.